Suchergebnisse - "Roca, Elisa"

PubPharm (14)

1

Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms : A Pooled Analysis

enthalten in: Neuroendocrinology | 2023

von Centonze, G. | Maisonneuve, P. | Prinzi, N. | +38

ErratumIn: Neuroendocrinology. 2024 Apr 8;:1. - PMID 38588655

2

A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019 : An Update From the TERAVOLT Registry

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Whisenant, J. | Baena, J. | Cortellini, A. | +69

3

The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma : Comprehensive clinical practice guidelines evaluation

enthalten in: Oral oncology | 2021

von Trevisiol, C. | Gion, M. | Vaona, A. | +5

4

Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis

enthalten in: Neuroendocrinology | 2021

von Milione, M. | Maisonneuve, P. | Grillo, F. | +24

5

Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions

enthalten in: Cells | 2020

von Carenzo, A. | Serafini, M. | Roca, E. | +8

6

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC) : A Large Retrospective Multicenter Study

enthalten in: Advances in therapy | 2020

von Russo, A. | Russano, M. | Franchina, T. | +28

7

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors : A multicenter, randomized, phase 3 trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2019

von Santo, A. | Pilotto, S. | Galetta, D. | +19

8

Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2019

von Fragni, M. | Galli, D. | Nardini, M. | +9

9

Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents

enthalten in: Endocrine | 2019

von Tucci, M. | Roca, E. | Ferrari, L. | +7

10

Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors : A pooled analysis with an additional case

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2019

von Roca, E. | Pozzari, M. | Vermi, W. | +6